Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Critical Reviews in Oncology/Hematology|February 6, 2010
Adjuvant endocrine therapy in postmenopausal breast cancer patients: does hormone receptor status influence decision-making?Fabio Puglisi, Alessandro Marco MinisiniPigment Cell & Melanoma Research|August 13, 2019
Neuroblastoma rat sarcoma mutated melanoma: That's what we got so farElisa Bertoli, Marco Giavarra, Maria Grazia Vitale, et al.Drugs|June 13, 2012
Overcoming treatment resistance in HER2-positive breast cancer: potential strategiesFabio Puglisi, Alessandro Marco Minisini, Carmine De Angelis, et al.Clinics and Practice|April 26, 2014
Fulminating septic shock from Clostridium perfringens in an early breast cancer patient with severe myalgia after docetaxel treatmentAlessandro Marco Minisini, Jessica Menis, Alessandro Follador, et al.Cells|June 2, 2021
CDK4/6 Inhibitors in Melanoma: A Comprehensive ReviewMattia Garutti, Giada Targato, Silvia Buriolla, et al.Current Oncology (Toronto, Ont.)|December 22, 2022
CDK4/6 Inhibitors as Upfront Treatment in a Patient with Breast Cancer Presenting with a Clinical Critic Situation: A Case Report and Review of the LiteratureGiada Targato, Lucia Bortot, Arianna Dri, et al.The Oncologist|May 29, 2015
Treatment of Metastatic Breast Cancer in a Real-World Scenario: Is Progression-Free Survival With First Line Predictive of Benefit From Second and Later Lines?Marta Bonotto, Lorenzo Gerratana, Donatella Iacono, et al.Breast (Edinburgh, Scotland)|February 28, 2025
Antibody-drug conjugates in elderly patients with breast cancerMarta Bonotto, Giulia De Pieri, Rocco Esposto, et al.Cancers|July 26, 2020
"To Anticipate": Neoadjuvant Therapy in Melanoma with a Focus on Predictive BiomarkersMattia Garutti, Silvia Buriolla, Elisa Bertoli, et al.Tumori|May 15, 2002
Amsterdam criteria II and endometrial cancer index cases for an accurate selection of HNPCC familiesMara Fornasarig, Alessandra Viel, Ettore Bidoli, et al.Pageof 5